Centene (NYSE:CNC) Rating Lowered to Buy at StockNews.com
Centene (NYSE:CNC – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a research note issued to investors on Thursday. CNC has been the topic of several other research reports.
Centene (CNC) Q4 2024 Earnings Call Transcript
Good day, and welcome to the Centene Corporation fourth quarter and full year 2024 earnings conference call. [Operator instructions] After today's presentation, there will be an opportunity to ask questions.
Centene stock slides 4% following Q4 earnings, forecast
Centene (CNC) stock slipped 4% Tuesday after the healthcare plan provider, which specializes in Medicaid services, issued its Q4 earnings report and 2025 forecast. Read more here.
Centene (CNC) Gets a Buy from Truist Financial
In a report released today, David S Macdonald from Truist Financial reiterated a Buy rating on Centene (CNC – Research Report). The company’s
Centene: Q4 Earnings Snapshot
The average estimate of five analysts surveyed by Zacks Investment Research was for earnings of 49 cents per share. The healthcare company posted revenue of $40.81 billion in the period, also topping Street forecasts.
Earnings call transcript: Centene Q4 2024 beats EPS forecast, stock dips
Centene Corp (NYSE:CNC) reported stronger-than-expected earnings for the fourth quarter of 2024, with an adjusted diluted EPS of $0.80, surpassing the forecast of $0.51. Despite this positive financial performance,
Centene (CNC) Q4 Earnings: How Key Metrics Compare to Wall Street Estimates
For the quarter ended December 2024, Centene (CNC) reported revenue of $40.81 billion, up 3.4% over the same period last year. EPS came in at $0.80, compared to $0.45 in the year-ago quarter. The reported revenue compares to the Zacks Consensus Estimate of $38.
Centene (NYSE:CNC) Beats Expectations in Strong Q4
Health coverage company Centene (NYSE:CNC) reported Q4 CY2024 results , with sales up 3.4% year on year to $40.81 billion. Its non-GAAP profit of $0.80 per share was 62.2% above analysts’ consensus estimates.
Obamacare Leads Centene To $3.3 Billion 2024 Profit As Medicaid Drops
Centene reported $3.3 billion in 2024 profits as Obamacare enrollment and premium revenue helped overcome a dip in Medicaid ...
Centene's shares slip on higher Medicaid costs
Centene beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strength in its commercial health ...
Healthcare Dive3d
Centene sets itself up for ‘equilibrium’ in 2025
The insurer also reported notable ACA growth for this year, though membership could tick back down through the second quarter ...
Centene cut to Hold at Argus after Q4 results
Centene (NYSE:CNC) stock was downgraded by Argus citing an uncertain outlook for its certain state-level operations and its Medicare Advantage business. Read more here.
Centene Corp. stock underperforms Tuesday when compared to competitors
Shares of Centene Corp. slid 5.45% to $61.29 Tuesday, on what proved to be an all-around positive trading session for the ...
Modern Healthcare3d
Centene's lower medical costs drive Q4 profit
Centene’s results buoyed investors after other insurance companies reported out-of-control costs for the quarter.
Health insurer Centene beats profit estimates on strength in commercial plans
Centene beat Wall Street estimates for fourth-quarter profit on Tuesday, helped by strength in its commercial health ...
1CNC : Insurance Firm Centene Sees Q4 Revenue Boost, Sticks To Annual Forecast
Centene raised its 2025 premium revenue outlook to $158 billion-$160 billion. Q4 results beat estimates with $40.8 billion in ...
Fierce Healthcare4d
Centene beats the Street with $283M in profit for Q4
Centene Corporation reported $283 million in profit for the fourth quarter of 2024, a notable bump from Q4 2023's haul of $45 ...
Centene (NYSE:CNC) Price Target Raised to $71.00 at Robert W. Baird
Centene (NYSE:CNC – Get Free Report) had its target price upped by equities researchers at Robert W. Baird from $66.00 to $71 ...